Kotaro Mitsutake
Overview
Explore the profile of Kotaro Mitsutake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shinya N, Seki M, Karaushi H, Asakura T, Yoshitake A, Mitsutake K
J Infect Chemother
. 2025 Feb;
31(4):102644.
PMID: 39922459
Introduction: Infective native aortic and iliac artery aneurysms, although rare, have high mortality rates of 21%-44 %. Diagnosis is often delayed owing to nonspecific symptoms. Treatment includes surgical intervention and...
2.
Koyama S, Watanabe N, Naruse H, Mitsutake K, Ebihara Y
J Infect Chemother
. 2024 Dec;
31(3):102590.
PMID: 39694325
Introduction: Urinary tract infections (UTIs) are one of the most common bacterial infections and a major cause of sepsis. It is important to promptly diagnose and treat UTIs. Method: We...
3.
Naruse H, Watanabe N, Ohta A, Shimizu Y, Fukushima T, Watanabe A, et al.
Diagn Microbiol Infect Dis
. 2024 Dec;
111(3):116626.
PMID: 39616689
This report describes a 6-year-old boy who developed non-tuberculosis mycobacteria (NTM) catheter-related bloodstream infection (CRBSI) during treatment for B-cell precursor acute lymphoblastic leukemia. A Hickman catheter was inserted before starting...
4.
Seki M, Kubosawa C, Ono M, Kamoshita F, Shimizu A, Mitsutake K
Infect Drug Resist
. 2024 Nov;
17:5011-5015.
PMID: 39554473
Background: Repeat positive results for SARS-CoV-2 by antigen detection test/RT-PCR in recovered COVID-19 patients were not very rare even when omicron variants became dominant, but the clinical features of patients...
5.
Mitsutake K, Shinya N, Seki M, Ohara T, Uemura K, Fukunaga M, et al.
J Infect Chemother
. 2024 Jun;
30(12):1259-1265.
PMID: 38876203
Background: Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan...
6.
Watanabe N, Koyama S, Maeda T, Karaushi H, Taji Y, Kawasaki Y, et al.
Cureus
. 2024 May;
16(4):e59043.
PMID: 38800333
Background In patients with hematologic malignancies, faster species identification is particularly important in the management of bloodstream infection because of their immunocompromised and neutropenic status. In the present study, we...
7.
Mitsutake K, Shinya N, Seki M, Ohara T, Uemura K, Fukunaga M, et al.
J Infect Chemother
. 2024 Mar;
30(9):860-866.
PMID: 38432557
Background: MRSA (methicillin-resistant Staphylococcus aureus)-infective endocarditis (IE) is associated with high morbidity and mortality. This study aimed to assess data from patients with MRSA-IE across multiple facilities in Japan, with...
8.
Fujikura Y, Ohno T, Seki M, Mitsutake K
J Infect Chemother
. 2023 Sep;
30(1):88-91.
PMID: 37678748
It is unclear whether anti-methicillin-resistant Staphylococcus aureus (MRSA) drugs should be uniformly administered to patients with pneumonia when MRSA is isolated from respiratory specimens. A systematic review was conducted to...
9.
Seki M, Karaushi H, Arai N, Hayashi T, Mitsutake K
Infect Drug Resist
. 2023 Jul;
16:4289-4295.
PMID: 37424669
Background: Secondary bacterial infection was initially rare in SARS-CoV-2 infectious disease (COVID-19) patients, but COVID-19-associated bacterial infectious diseases have recently been increasing. Furthermore, it might be difficult to distinguish COVID-19...
10.
Kawasuji H, Nagaoka K, Tsuji Y, Kimoto K, Takegoshi Y, Kaneda M, et al.
Antibiotics (Basel)
. 2023 Apr;
12(4).
PMID: 37107059
Vancomycin (VCM) and daptomycin (DAP) are standard therapies for methicillin-resistant (MRSA) bacteremia, despite concerns regarding clinical utility and growing resistance. Linezolid (LZD) affords superior tissue penetration to VCM or DAP...